Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A27548 | 18086620 | Hepatobiliary Pancreat Dis Int | Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. | 2007 | Details |
| A27549 | 18086506 | J Hepatol | Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. | 2007 | Details |
| A27551 | 18081738 | Aliment Pharmacol Ther | Adipokines and cytokines in non-alcoholic fatty liver disease. | 2007 | Details |
| A27554 | 18075282 | J Endocrinol Invest | Plasminogen activator inhibitor-1 and thrombin activatable fibrinolysis inhibitor levels in non-alcoholic steatohepatitis. | 2007 | Details |
| A27557 | 18074733 | Acta Gastroenterol Belg | Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention. | 2008 | Details |
| A27559 | 18072723 | Mol Pharm | Nonalcoholic fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets. | 2007 | Details |
| A27561 | 18062158 | Praxis (Bern 1994) | [Non-alcoholic steatohepatitis--a new epidemic]. | 2007 | Details |
| A27565 | 18056890 | Diabetes Care | Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. | 2007 | Details |
| A27566 | 18054554 | Gastroenterology | Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. | 2007 | Details |
| A27571 | 18035683 | Verh Dtsch Ges Pathol | [Alcoholic and non-alcoholic steatohepatitis]. | 2005 | Details |
| A27572 | 18031368 | J Gastroenterol Hepatol | Significant correlations between severe fatty liver and risk factors for metabolic syndrome. | 2007 | Details |
| A27575 | 18022391 | FEBS Lett | Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome. | 2007 | Details |
| A27579 | 18007554 | Ann Hepatol | Dipeptidyl peptidase IV (DDP IV) in NASH patients. | 2008 | Details |
| A27580 | 18007551 | Ann Hepatol | Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions. | 2008 | Details |
| A27581 | 18004085 | Am J Med Sci | The effects of weight loss on normal transaminase levels in obese patients. | 2007 | Details |
| A27585 | 17986744 | Indian J Gastroenterol | Insulin tolerance test is comparable to homeostasis model assessment for insulin resistance in patients with nonalcoholic fatty liver disease. | 2008 | Details |
| A27587 | 17983937 | Endocrinol Metab Clin North Am | Use of insulin sensitizers in NASH. | 2007 | Details |
| A27588 | 17983472 | BMC Gastroenterol | Prevalence and factors associated with the presence of non alcoholic fatty liver disease in an apparently healthy adult population in primary care units. | 2007 | Details |
| A27593 | 17964913 | Med Clin North Am | Nonalcoholic fatty liver disease as a complication of insulin resistance. | 2007 | Details |
| A27596 | 17951208 | Am J Clin Pathol | Pathology of nonalcoholic fatty liver disease. | 2007 | Details |
| A27601 | 17934820 | Dig Dis Sci | Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease. | 2007 | Details |
| A27604 | 17919226 | Liver Int | Treating nonalcoholic fatty liver disease. | 2007 | Details |
| A27605 | 17918488 | Rev Med Suisse | [Liver disease in obese patients]. | 2007 | Details |
| A27611 | 17906183 | J Am Coll Nutr | Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men. | 2007 | Details |
| A27612 | 17904683 | Diabetes Res Clin Pract | Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. | 2007 | Details |
| A27626 | 17890486 | Obesity (Silver Spring) | Hepatic steatosis and increased adiposity in mice consuming rapidly vs. slowly absorbed carbohydrate. | 2007 | Details |
| A27629 | 17877759 | Clin Endocrinol (Oxf) | Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases. | 2007 | Details |
| A27630 | 17877502 | Hepatol Res | Epidemiology of hepatocellular carcinoma in USA. | 2007 | Details |
| A27631 | 17875176 | J Intern Med | Obesity-induced inflammation: a metabolic dialogue in the language of inflammation. | 2007 | Details |
| A27638 | 17846888 | Dig Dis Sci | Fibrogenesis in fatty liver associated with obesity and diabetes mellitus type 2. | 2007 | Details |
| A27639 | 17845148 | Expert Opin Ther Targets | Present and future therapeutic strategies in non-alcoholic fatty liver disease. | 2007 | Details |
| A27640 | 17826687 | Drug Discov Today | Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD). | 2007 | Details |
| A27641 | 17823431 | Am J Clin Nutr | Nitrosative stress predicts the presence and severity of nonalcoholic fatty liver at different stages of the development of insulin resistance and metabolic syndrome: possible role of vitamin A intake. | 2007 | Details |
| A27643 | 17786142 | Ann Hepatol | Prevalence of non-alcoholic fatty liver disease: population based study. | 2007 | Details |
| A27647 | 17766001 | Diabetes Res Clin Pract | Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance. | 2007 | Details |
| A27650 | 17761893 | J Endocrinol | Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. | 2007 | Details |
| A27651 | 19669329 | Hepatol Int | Current and novel therapies for the treatment of nonalcoholic steatohepatitis. | 2007 | Details |
| A27652 | 17729403 | World J Gastroenterol | Pathogenesis and management issues for non-alcoholic fatty liver disease. | 2007 | Details |
| A27653 | 17728149 | Ann Epidemiol | Nonalcoholic fatty liver disease. | 2007 | Details |
| A27656 | 17722791 | Tunis Med | [Role of mitochondrial dysfunction in non-alcoholic steatohepatitis]. | 2003 | Details |
| A27657 | 17716660 | FEBS Lett | Role of ChREBP in hepatic steatosis and insulin resistance. | 2007 | Details |
| A27660 | 17567476 | J Gastroenterol Hepatol | Role of adipocytokines in hepatic fibrogenesis. | 2007 | Details |
| A27662 | 17567459 | J Gastroenterol Hepatol | Role of mitochondria in non-alcoholic fatty liver disease. | 2007 | Details |
| A27663 | 17567458 | J Gastroenterol Hepatol | Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)? | 2007 | Details |
| A27665 | 17711101 | Rocz Panstw Zakl Hig | Nonalcoholic fatty liver disease as a feature of the metabolic syndrome. | 2007 | Details |
| A27667 | 17709876 | Cell Biochem Biophys | Childhood obesity and insulin resistance. | 2007 | Details |
| A27669 | 17708287 | Hepatogastroenterology | Factors affecting the serum levels of adipokines in Korean male patients with nonalcoholic fatty liver disease. | 2007 | Details |
| A27675 | 17694770 | Niger J Med | Diabetes co-existing with chronic liver disease: clinical features and response to therapy. | 2007 | Details |
| A27676 | 17691915 | Curr Drug Discov Technol | Current treatment strategies for non-alcoholic fatty liver disease (NAFLD). | 2007 | Details |
| A27677 | 17690317 | Arterioscler Thromb Vasc Biol | Fatty liver: a novel component of the metabolic syndrome. | 2007 | Details |
| A27679 | 17684197 | Am J Clin Nutr | Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. | 2007 | Details |
| A27680 | 17683497 | J Gastroenterol Hepatol | Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet. | 2007 | Details |
| A27683 | 17675901 | J Cardiometab Syndr | Nonalcoholic steatohepatitis and the cardiometabolic syndrome. | 2006 | Details |
| A27686 | 17669243 | Zhonghua Gan Zang Bing Za Zhi | [The relationship between insulin resistance and adiponectin gene expression in nonalcoholic fatty liver disease]. | 2007 | Details |
| A27687 | 17667992 | Nat Clin Pract Gastroenterol Hepatol | Evaluation and management of obesity-related nonalcoholic fatty liver disease. | 2007 | Details |
| A27689 | 17659713 | World J Gastroenterol | Visceral fat and insulin resistance as predictors of non-alcoholic steatohepatitis. | 2007 | Details |
| A27690 | 17659704 | World J Gastroenterol | Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. | 2007 | Details |
| A27691 | 17657385 | Singapore Med J | Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore. | 2007 | Details |
| A27693 | 17655622 | Acta Paediatr | Nonalcoholic fatty liver disease in overweight children and adolescents. | 2007 | Details |
| A27695 | 17654601 | Hepatology | Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice. | 2007 | Details |
| A27697 | 17653654 | J Gastroenterol | High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. | 2007 | Details |
| A27702 | 17619535 | Acta Gastroenterol Belg | Pathogenesis of steatohepatitis: insights from the study of animal models. | 2007 | Details |
| A27703 | 17618414 | Diabetologia | Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice. | 2007 | Details |
| A27704 | 17610277 | Hepatology | The impact of fat distribution on the severity of nonalcoholic fatty liver disease and metabolic syndrome. | 2007 | Details |
| A27705 | 17608855 | J Gastroenterol Hepatol | Effects of nonalcoholic fatty liver disease on the development of metabolic disorders. | 2007 | Details |
| A27708 | 17605315 | Nutr Rev | Obesity and nonalcoholic fatty liver disease. | 2007 | Details |
| A27710 | 17596883 | Hepatology | A comparison of associations of alanine aminotransferase and gamma-glutamyltransferase with fasting glucose, fasting insulin, and glycated hemoglobin in women with and without diabetes. | 2007 | Details |
| A27712 | 17593595 | Medicina (B Aires) | Alanine-aminotransferase: an early marker for insulin resistance? | 2007 | Details |
| A27715 | 17566116 | Am J Physiol Endocrinol Metab | Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice. | 2007 | Details |
| A27722 | 17560682 | J Hepatol | Nonalcoholic fatty liver disease in women with polycystic ovary syndrome. | 2007 | Details |
| A27723 | 17560678 | J Hepatol | Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis. | 2007 | Details |
| A27724 | 17560098 | Nutr Metab Cardiovasc Dis | Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question. | 2007 | Details |
| A27726 | 17558337 | J Acquir Immune Defic Syndr | HIV-positive patients with nonalcoholic fatty liver disease have a lower body mass index and are more physically active than HIV-negative patients. | 2007 | Details |
| A27728 | 17552019 | World J Gastroenterol | Therapeutic strategies for pediatric non-alcoholic fatty liver disease: a challenge for health care providers. | 2007 | Details |
| A27732 | 17544977 | Clin Liver Dis | Non-alcoholic steatohepatitis in children. | 2007 | Details |
| A27734 | 17544974 | Clin Liver Dis | Metabolic syndrome and NASH. | 2007 | Details |
| A27735 | 17544973 | Clin Liver Dis | Pathogenesis of non-alcoholic steatohepatitis: human data. | 2007 | Details |
| A27736 | 17544972 | Clin Liver Dis | Pathogenesis of NASH: animal models. | 2007 | Details |
| A27741 | 17542290 | Trop Gastroenterol | Nonalcoholic fatty liver disease in India--is it different? | 2007 | Details |
| A27744 | 17542278 | Rev Gastroenterol Mex | [Prevalence of NAFLD and metabolic syndrome in asymtomatics subjects]. | 2007 | Details |
| A27749 | 17526931 | J Biol Chem | Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance. | 2007 | Details |
| A27754 | 17515890 | Nat Clin Pract Endocrinol Metab | Nonalcoholic fatty liver disease: from pathogenesis to patient care. | 2007 | Details |
| A27755 | 17512085 | J Hepatol | Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. | 2007 | Details |
| A27756 | 17511754 | Am J Gastroenterol | Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis. | 2007 | Details |
| A27759 | 17498258 | Liver Int | The expression of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats. | 2007 | Details |
| A27761 | 17498218 | J Gastroenterol Hepatol | What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? | 2007 | Details |
| A27762 | 17496361 | Indian J Med Res | Antioxidants: do they have a role in the treatment of insulin resistance? | 2007 | Details |
| A27763 | 17496360 | Indian J Med Res | The metabolic syndrome in South Asians: continuing escalation & possible solutions. | 2007 | Details |
| A27769 | 17484887 | Gastroenterology | Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide. | 2007 | Details |
| A27770 | 17483247 | J Clin Pathol | A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease. | 2007 | Details |
| A27775 | 17476088 | Indian J Pediatr | Non-alcoholic fatty liver disease and childhood obesity. | 2007 | Details |
| A27776 | 17475935 | Diabetes Care | Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults. | 2007 | Details |
| A27777 | 17471859 | Rev Gastroenterol Mex | Nonalcoholic fatty liver disease. | 2005 | Details |
| A27781 | 17464986 | Hepatology | Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH? | 2007 | Details |
| A27782 | 17464461 | J Gastroenterol | Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease. | 2007 | Details |
| A27786 | 17452309 | Orv Hetil | [Common occurrence of non-alcoholic fatty liver disease and cholecystolithiasis]. | 2007 | Details |
| A27787 | 17449148 | Clin Nutr | Update on non-alcoholic fatty liver disease in children. | 2007 | Details |
| A27788 | 17445934 | J Hepatol | Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem? | 2007 | Details |
| A27792 | 17420951 | Dig Dis Sci | The clinicopathological profile of Indian patients with nonalcoholic fatty liver disease (NAFLD) is different from that in the West. | 2007 | Details |
| A27793 | 17419265 | Hepatogastroenterology | Fertile females with nonalcoholic fatty liver disease (NAFLD) have higher levels of ALT than postmenopausal females: implications for the influence of fertility on NAFLD. | 2007 | Details |